Zoetis Inc (NYSE:ZTS)
$ 169.04 0.91 (0.54%) Market Cap: 77.13 Bil Enterprise Value: 81.93 Bil PE Ratio: 32.57 PB Ratio: 15.27 GF Score: 96/100

Zoetis Inc at Morgan Stanley Healthcare Conference Transcript

Sep 10, 2019 / 04:20PM GMT
Release Date Price: $123.03 (-2.87%)
David Reed Risinger
Morgan Stanley, Research Division - MD in Equity Research and United States Pharmaceuticals Analyst

So I think we should get started. Thanks, everyone, for joining this session with Zoetis. It's very much my pleasure to welcome two leaders of the management team. I did want to mention that we need to refer you to disclaimers at www.morganstanley.com/researchdisclosures.

So with us today, we have Kristin Peck, who is Executive Vice President and Group President; and Glenn David, who's Executive Vice President and CFO. So thanks for joining us.

Just to tell you a little bit about their backgrounds briefly. So Kristin oversees U.S. operations, business development and strategy at Zoetis. And she has been in that senior role with some different titles of responsibility since 2015, when she joined -- or you joined with Pfizer, sorry, as part of a spin, but you took on that role in 2015. And then Glenn David has over 20 years of experience in finance and operations and played a key

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot